NCT02753374Not yet recruiting
Registry Study on Cystic Fibrosis in Chinese Children
Registry Study on Cystic Fibrosis in Chinese Children-a Multicenter, Prospective Cohort Study
Source: ClinicalTrials.gov · Last updated 28 Apr 2016 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is a multicenter, prospective cohort study of patients diagnosed with cystic fibrosis, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 10 years.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 26 Apr 2016
- Start date
- May 2016
- Primary completion date
- May 2030
- Lead sponsor
- Beijing Children's Hospital
- Diseases
- Cystic fibrosis
- NCT number
- NCT02753374
What you commit to
- Study type: Observational
- Planned participants: 100
- From May 2016 to the primary completion date, May 2030
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- It is unable to provide complete medical records or the current condition can not accept the diagnosis process.
Other
- Subject will be excluded if she or he has one of the following:
- She or he does not agree to participate in the test.
Who the study is looking for
- Age 0\~18 years old
- Any organ system symptoms consistent with CF, such as chronic sinopulmonary disease, gastrointestinal and nutritional abnormalities, obstructive azoospermia or having siblings with CF
- CFTR dysfunction indicated by elevated sweat chloride levels ≥60 mmol/L twice, or one sweat chloride levels ≥40 mmol/L plus presence of two pathogenic CFTR mutations on different alleles
- Probable CF patients with sweat chloride levels among 40\~59 mmol/L plus with presence of 0-1 pathogenic CFTR mutation
- Consent to provide the related clinical specimen to the certain hospital
- The guardians of the patients fully understand the purpose of the study, volunteer their children to participate in this study and sign informed consent.
Age in the registry: - to 18 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.